RESEARCH PAPER
Morbidity and mortality due to cervical cancer in Poland after introduction of the Act – National Programme for Control of Cancerous Diseases
 
More details
Hide details
1
Department for Health Problems of Ageing, Institute of Rural Health in Lublin, Poland
2
Higher School of Public Health, Zielona Góra, Poland
3
Chair of Health Sciences, Medical University, Poznań, Poland
4
Department of Pathology and Rehabilitation of Speech, Medical University in Lublin, Lublin, Poland
 
Ann Agric Environ Med. 2012;19(4):680–685
KEYWORDS
ABSTRACT
In 2005 in Poland, referring to the recommendations by the National Health Programme and recommendations by the European Union, the National Programme for Control of Cancerous Diseases was implemented by virtue of the Act, one of its basic assumptions being an improvement of oncologic awareness among the Polish population. It is expected that the result of actions in this respect will be an increase in reporting rates for prophylactic examinations and a decrease in the number of deaths due to cancerous diseases. The objective of the study was presentation of the analysis of morbidity and mortality due to cervical cancer in Poland and in individual regions, after the implementation of the National Programme for Control of Cancerous Diseases. The data was obtained from the Oncology Centre and from the computer Information System for Prophylaxis Monitoring (SIMP). In the analysis of obtained results, qualitative variables distribution was defined by means of the following values: number of instances (n) and frequency (%) with which they occur in a given category. The frequencies with which these categories of variables occur were compared by means of the chi-squared test with Yates’ correction. The permissible error probability of the first type (p-value) is assumed to equal 0.05. The statistical assessment of results was performed by means of STATISTICA PL statistical software, version 9.0. In Poland in 2010, as many as 3,078 female patients suffered from with cervical cancer, compared with 3,263 in 2005, i.e. prior to implementation of The National Cancer Prevention Programme Act. Therefore, it can be concluded that there was a decline in cervical cancer incidence of 5.7%. As regards the mortality rate, there was a decline of 3.4%. A comparison of the cervical cancer morbidity and mortality rate for Poland and its provinces between 2005-2010 showed statistically significant differences only for morbidity rate – a decline in frequency in the entire Polish territory and in the following provinces: Lublin, Łódź, Lesser Poland, and Greater Poland, as well as an increase in the morbidity rate in Kuyavian-Pomeranian province.
 
REFERENCES (16)
1.
Ustawa o ustanowieniu programu wieloletniego “Narodowy program zwalczania chorób nowotworowych” z dnia 1 lipca 2005 r. Dz. U. Nr 143, poz. 1200, z 2005.
 
2.
Zarządzenie Nr 86/2005 z dnia 13 października 2005 r. Prezesa Narodowego Funduszu Zdrowia.
 
3.
Kędzia W, Spaczyński M. Nowe metody wykrywania śródnabłonkowej neoplazji szyjki macicy. (W:) Spaczyński M, Kędzia W, Nowak-Markwitz E. Rak Szyjki Macicy. Profilaktyka, diagnostyka leczenie. PZWL Warszawa 2009.
 
4.
Krajowa Baza Danych Nowotworowych. http://www.onkologia.org.pl/pl... (access: 18.10.2012).
 
5.
Boyle P, Levin B. World Cancer Report 2008. WHO, Lyon 2008.
 
6.
Globocan database 2008 (www-dep.iarc.fr/globocan/datab...) (access: 18.10.2012).
 
7.
Wronkowski Z, Zwierko M, Nowacki MP. Raport z Programu modelowego skryningu raka piersi i raka szyjki macicy w Polsce, 1999 – 2000. COI, Warszawa 2002.
 
8.
International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Brit Med J. 1986; 293(6548): 659–664.
 
9.
Zatoński W. (ed.) Zatoński W, Lissowska J, Didkowska J, Jablońska J. Europejski Kodeks Walki z Rakiem. Medycyna Praktyczna: COI, Warszawa 2003.
 
10.
Sasieni PD, Cuzick J, Lynch – Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Coordinating Network for Cervical Screening Working Group. Brit J Cancer. 1996; 73(8): 1001–1005.
 
11.
Sigurdsson K. Trends in cervical intra – epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand. 1999; 78: 486–492.
 
12.
Spaczyński M. Polskie Towarzystwo Ginekologiczne: Kędzia W, Basta A, Bidziński M, Bręborowicz J, Bręborowicz GH, Dębski R, Drews K, Grabiec M, Knapp P, Niecewicz R, Opala T, Olejek A, Pawelczyk L, Pertyński T, Poręba R, Poznański J, Radowicki S, Rzepka – Górska I. Rekomendacje PTG: Diagnostyka, pro laktyka i wczesne wykrywanie raka szyjki macicy. Ginekol Dypl. 2008; 10: 158–160.
 
13.
Spaczyński M, Michalska M, Januszek–Michalecka L. Raport z realizacji Populacyjnego Programu Profilaktyki i Wczesnego Wykrywania Raka Szyjki Macicy. Ginekol Pol. 2009; 80: 220–226.
 
14.
Ackerson K, Preston S. A decision theory perspective on why women do or do not decide to have cancer screening: systematic review. J Adv Nurs. 2009; 65: 1130–1140.
 
15.
Chew-Graham C, Mole E, Evans L. Informed consent? How do primary care professionals prepare women for cervical smears: a qualitative study. Patient Educ Couns. 2006; 61: 381–388.
 
16.
Didkowaska J, Wojciechowska U, Zatoński W. Prediction of cancer incidence and mortality in Poland up to the Lear 2025. COI, 2009: 51-55.
 
eISSN:1898-2263
ISSN:1232-1966